Abstract
α,α-Difluoro-substituted organozinc reagents generated from conventional organozinc compounds and difluorocarbene couple with 1-bromoalkynes affording gem-difluorinated alkynes. The cross-coupling proceeds in the presence of catalytic amounts of copper iodide in dimethylformamide under ligand-free conditions.
Keywords: 1-bromoalkynes, cross-coupling, organofluorine compounds, organozinc reagents
Introduction
gem-Difluorinated organic compounds have attracted increasing attention nowadays due to their applicability in medicinal chemistry [1–2] and other fields. Indeed, unique stereoelectronic properties of the CF2-unit may be exploited in conformational analysis [3–5], carbohydrate and peptide research [6–7], and reaction engineering [8–9].
Typically, the difluoromethylene fragment is created by deoxyfluorination, which requires harsh or hazardous conditions [10–11]. Alternatively, functional group manipulations starting from available CF2-containing building blocks can be considered, but multistep sequences render this approach laborious [12–14]. Difluoro-substituted cyclopropanes and cyclopropenes constitute a specific class of compounds accessible by difluorocarbene addition to multiple bonds [15].
Recently, we proposed a general method for assembling gem-difluorinated structures from organozinc reagents 1, difluorocarbene, and a terminating electrophile [16–21] (Scheme 1). (Bromodifluoromethyl)trimethylsilane [16–18] or potassium bromodifluoroacetate [19] can be used as precursors of difluorocarbene. In this process, the use of C-electrophiles is particularly important since it allows for the formation of two C–C bonds within one experimental run. Previously, as C-electrophiles in this methodology, only allylic substrates [17] and nitrostryrenes (with the NO2 serving as a leaving group) [20], were employed. Herein, we report that 1-bromoalkynes, which are known to be involved in reactions with various organometallic compounds [22–27], can be used as suitable coupling partners for difluorinated organozinc compounds 2. This reaction provides straightforward access to α,α-difluorinated alkynes [13–14,28–31]. Our method is based on facile zinc/copper exchange allowing for versatile couplings described for non-fluorinated organozinc compounds [32–37].
Scheme 1.
Reaction of organozinc compounds.
Results and Discussion
Organozinc compound 2a generated from benzylzinc bromide was first evaluated in a reaction with haloalkynes derived from phenylacetylene (Table 1). First, most reactive iodo-substituted alkyne 3a-I (X = I) was evaluated in the presence of copper iodide (10 mol %). Expected product 4a was formed in 12% yield, but its yield was tripled simply by adding 2 equiv of DMF additive (Table 1, entries 1 and 2). However, in these experiments, the reaction mixtures contained about 40% of (2,2-difluoro-2-iodoethyl)benzene (PhCH2CF2I) arising from zinc/iodine exchange between 2a and the iodoalkyne. Chloroalkyne 3a-Cl was markedly less reactive, likely because of the strong carbon–chlorine bond. Fortunately, bromoalkyne 3a-Br provided the best results, with the optimal conditions involving the use of DMF as a solvent and only 5 mol % of copper iodide at 0 °C to room temperature, which afforded the coupling product in 79% isolated yield (Table 1, entry 5). The addition of various ligands, as well as the use of other copper salts, did not had a beneficial effect.
Table 1.
Optimization studies.
![]() | |||||||
| Entry | X | 2a (equiv) | Conditions | Solvent | CuI (equiv) | Additive (equiv) | Yield of 4a, %a |
| 1 | I | 2 | −50 °C → rt; 4 h at rt | MeCN | 0.1 | – | 12 |
| 2 | I | 1.3 | −50 °C → rt; 4 h at rt | MeCN | 0.1 | DMF (2) | 35 |
| 3 | Cl | 2 | 0 °C → rt; 16 h at rt | MeCN | 0.1 | DMF (2) | 32 |
| 4 | Br | 1.5 | 0 °C → rt; 16 h at rt | MeCN | 0.1 | DMF (2) | 60 |
| 5 | Br | 1.5 | 0 °C → rt; 16 h at rt | DMF | 0.05 | – | 79b |
aDetermined by 19F NMR with internal standard. bIsolated yield.
Under the optimized conditions, a series of organozinc compounds 2 were coupled with bromoalkynes 3 (Table 2). Good yields of coupling products 4 were typically achieved. The reaction tolerates ester groups or TBS-protected hydroxy groups. Aromatic iodide also remains unaffected (Table 2, entry 2).
Table 2.
Reaction of organozinc compounds 2 with bromoalkynes 3.
![]() | ||||
| Entry | 2 | 3 | 4 | Yield of 4, %a |
| 1 |
![]() 2a |
![]() 3b |
![]() 4b |
84 |
| 2 | 2a |
![]() 3c |
![]() 4c |
82 |
| 3 | 2a |
![]() 3d |
![]() 4d |
70 |
| 4 | 2a |
![]() 3e |
![]() 4e |
84 |
| 5 | 2a |
![]() 3f |
![]() 4f |
67 |
| 6b | 2a |
![]() 3g |
![]() 4g |
80 |
| 7b | 2a |
![]() 3h |
![]() 4h |
75 |
| 8 |
![]() 2b |
![]() 3a-Br |
![]() 4i |
80 |
| 9 |
![]() 2e |
![]() 3a-Br |
![]() 4j |
81 |
| 10 |
![]() 2c |
![]() 3a-Br |
![]() 4k |
72 |
| 11b |
![]() 2c |
![]() 3g |
![]() 4l |
71 |
| 12b |
![]() 2d |
![]() 3g |
![]() 4m |
62 |
aIsolated yield. bThe crude product was desilylated.
As for the mechanism, we believe that the reaction starts with the zinc/copper exchange resulting in the formation of fluorinated organocopper species 5 (Scheme 2). Compound 5 interacts with bromoalkyne 3 either by oxidative addition generating copper(III) intermediate 6 or by triple bond carbometallation [38] generating copper(I) intermediate 7. Subsequent reductive elimination (from 6) or β-elimination (from 7) leads to the product and regenerates the copper(I) catalyst.
Scheme 2.
Proposed mechanism.
Conclusion
In summary, a method for the copper-catalyzed coupling of α,α-difluoro-substituted organozinc compounds with 1-bromoalkynes has been developed. The reaction is performed under mild conditions affording gem-difluoro-substituted alkynes in good yields.
Supporting Information
Full experimental details, compound characterization, and copies of NMR spectra.
Acknowledgments
This work was supported by the Ministry of Science (project MD-3256.2015.3) and Russian Foundation for Basic Research (projects 14-03-00293, 14-03-31253, 13-03-12074).
This article is part of the Thematic Series "Copper catalysis in organic synthesis".
References
- 1.Ojima I, editor. Fluorine in Medicinal Chemistry and Chemical Biology. Chichester: John Wiley & Sons; 2009. [Google Scholar]
- 2.Bégué J-P, Bonnet-Delpon D. Bioorganic and Medicinal Chemistry of Fluorine. Hoboken, New Jersey: John Wiley & Sons; 2008. [DOI] [Google Scholar]
- 3.O'Hagan D, Wang Y, Skibinski M, Slawin A M Z. Pure Appl Chem. 2012;84:1587–1595. doi: 10.1351/PAC-CON-11-09-26. [DOI] [Google Scholar]
- 4.Wang Y, Callejo R, Slawin A M Z, O'Hagan D. Beilstein J Org Chem. 2014;10:18–25. doi: 10.3762/bjoc.10.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Urbina-Blanco C A, Skibinski M, O'Hagan D, Nolan S P. Chem Commun. 2013;49:7201–7203. doi: 10.1039/c3cc44312d. [DOI] [PubMed] [Google Scholar]
- 6.Leclerc E, Pannecoucke X, Ethève-Quelquejeu M, Sollogoub M. Chem Soc Rev. 2013;42:4270–4283. doi: 10.1039/C2CS35403A. [DOI] [PubMed] [Google Scholar]
- 7.Kubyshkin V S, Mykhailiuk P K, Afonin S, Ulrich A S, Komarov I V. Org Lett. 2012;14:5254–5257. doi: 10.1021/ol302412a. [DOI] [PubMed] [Google Scholar]
- 8.Baskin J M, Prescher J A, Laughlin S T, Agard N J, Chang P V, Miller I A, Lo A, Codelli J A, Bertozzi C R. Proc Natl Acad Sci U S A. 2007;104:16793–16797. doi: 10.1073/pnas.0707090104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Codelli J A, Baskin J M, Agard N J, Bertozzi C R. J Am Chem Soc. 2008;130:11486–11493. doi: 10.1021/ja803086r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Tozer M J, Herpin T F. Tetrahedron. 1996;52:8619–8683. doi: 10.1016/0040-4020(96)00311-0. [DOI] [Google Scholar]
- 11.Al-Maharik N, O'Hagan D. Aldrichimica Acta. 2011;44:65–75. [Google Scholar]
- 12.Qing F-L, Zheng F. Synlett. 2011:1052–1072. doi: 10.1055/s-0030-1259947. [DOI] [Google Scholar]
- 13.Belhomme M-C, Besset T, Poisson T, Pannecoucke X. Chem – Eur J. 2015;21:12836–12865. doi: 10.1002/chem.201501475. [DOI] [PubMed] [Google Scholar]
- 14.Gao B, Ni C, Hu J. Chimia. 2014;68:414–418. doi: 10.2533/chimia.2014.414. [DOI] [PubMed] [Google Scholar]
- 15.Dolbier W R, Jr, Battiste M A. Chem Rev. 2003;103:1071–1098. doi: 10.1021/cr010023b. [DOI] [PubMed] [Google Scholar]
- 16.Levin V V, Zemtsov A A, Struchkova M I, Dilman A D. Org Lett. 2013;15:917–919. doi: 10.1021/ol400122k. [DOI] [PubMed] [Google Scholar]
- 17.Zemtsov A A, Kondratyev N S, Levin V V, Struchkova M I, Dilman A D. J Org Chem. 2014;79:818–822. doi: 10.1021/jo4024705. [DOI] [PubMed] [Google Scholar]
- 18.Smirnov V O, Struchkova M I, Arkhipov D E, Korlyukov A A, Dilman A D. J Org Chem. 2014;79:11819–11823. doi: 10.1021/jo5023537. [DOI] [PubMed] [Google Scholar]
- 19.Levin V V, Zemtsov A A, Struchkova M I, Dilman A D. J Fluorine Chem. 2015;171:97–101. doi: 10.1016/j.jfluchem.2014.08.021. [DOI] [Google Scholar]
- 20.Kondratyev N S, Levin V V, Zemtsov A A, Struchkova M I, Dilman A D. J Fluorine Chem. 2015;176:89–92. doi: 10.1016/j.jfluchem.2015.06.001. [DOI] [Google Scholar]
- 21.Smirnov V O, Maslov A S, Levin V V, Struchkova M I, Dilman A D. Russ Chem Bull. 2014;63:2564–2566. doi: 10.1007/s11172-014-0778-1. [DOI] [Google Scholar]
- 22.Thaler T, Guo L-N, Mayer P, Knochel P. Angew Chem, Int Ed. 2011;50:2174–2177. doi: 10.1002/anie.201006879. [DOI] [PubMed] [Google Scholar]
- 23.Corpet M, Bai X-Z, Gosmini C. Adv Synth Catal. 2014;356:2937–2942. doi: 10.1002/adsc.201400369. [DOI] [Google Scholar]
- 24.Cornelissen L, Lefrancq M, Riant O. Org Lett. 2014;16:3024–3027. doi: 10.1021/ol501140p. [DOI] [PubMed] [Google Scholar]
- 25.Wang S, Wang M, Wang L, Wang B, Li P, Yang J. Tetrahedron. 2011;67:4800–4806. doi: 10.1016/j.tet.2011.05.031. [DOI] [Google Scholar]
- 26.Castagnolo D, Botta M. Eur J Org Chem. 2010:3224–3228. doi: 10.1002/ejoc.201000393. [DOI] [Google Scholar]
- 27.Brand J P, Waser J. Chem Soc Rev. 2012;41:4165–4179. doi: 10.1039/c2cs35034c. [DOI] [PubMed] [Google Scholar]
- 28.Besset T, Poisson T, Pannecoucke X. Eur J Org Chem. 2014:7220–7225. doi: 10.1002/ejoc.201402937. [DOI] [Google Scholar]
- 29.Arimitsu S, Fernández B, del Pozo C, Fustero S, Hammond G B. J Org Chem. 2008;73:2656–2661. doi: 10.1021/jo7025965. [DOI] [PubMed] [Google Scholar]
- 30.Hammond G B. J Fluorine Chem. 2006;127:476–488. doi: 10.1016/j.jfluchem.2005.12.024. [DOI] [Google Scholar]
- 31.Xu B, Mae M, Hong J A, Li Y, Hammond G B. Synthesis. 2006:803–806. doi: 10.1055/s-2006-926334. [DOI] [Google Scholar]
- 32.Malosh C F, Ready J M. J Am Chem Soc. 2004;126:10240–10241. doi: 10.1021/ja0467768. [DOI] [PubMed] [Google Scholar]
- 33.Thapa S, Kafle A, Gurung S K, Montoya A, Riedel P, Giri R. Angew Chem, Int Ed. 2015;54:8236–8240. doi: 10.1002/anie.201502379. [DOI] [PubMed] [Google Scholar]
- 34.Karstens W F J, Moolenaar M J, Rutjes F P J T, Grabowska U, Speckamp W N, Hiemstra H. Tetrahedron Lett. 1999;40:8629–8632. doi: 10.1016/S0040-4039(99)01808-0. [DOI] [Google Scholar]
- 35.Knochel P. Organomagnesium and Organozinc Chemistry. In: Schlosser M, editor. Organometallics in Synthesis. Hoboken, New Jersey: John Wiley & Sons, Inc.; 2013. pp. 223–372. [DOI] [Google Scholar]
- 36.Knochel P. In: Metal-Catalyzed Cross-Coupling Reactions. Diederich F, Stang P J, editors. Weinheim: Wiley-VCH; 1998. pp. 387–419. [Google Scholar]
- 37.Geurts K, Fletcher S P, van Zijl A W, Minnaard A J, Feringa B L. Pure Appl Chem. 2008;80:1025–1037. doi: 10.1351/pac200880051025. [DOI] [Google Scholar]
- 38.Cahiez G, Gager O, Buendia J. Angew Chem, Int Ed. 2010;49:1278–1281. doi: 10.1002/anie.200905816. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Full experimental details, compound characterization, and copies of NMR spectra.


































